- Jason Bond Picks (Member)
- Posts
- SURG, DATS, WKEY, BBAI swings
SURG, DATS, WKEY, BBAI swings
Why interest rates are coming down without cuts
*together with ProsperityPub
⚠️LIVE Trading & Deal ENDING!⚠️
Newton Indicator 50% Savings Ends At 10AM.
LIVE Trading Today at 10AM… Only For Members!
Interest rates are coming down without Powell cutting rates. It would appear President Trump’s plan, alongside Musk’s DOGE is working.
Ultimately this is good for small-cap stocks so I’m excited about JasonBondPicks — as I’m sure you’ve noticed by the increase in alerts.
I’ve gone old school JasonBondPicks with the livestream in chat as well as my journal using Google sheets. The goal is to get the $50,000 balance to $100,000 as quickly as possible — as that’s the number I can scale very fast with, ideally to 7-figures within a few years or less.

Results not typical. Trading is hard. Nothing is guaranteed.
Into the session I’m holding 4 swings and 1 long-term trade.
SURG and DATS are fibonacci retracement trades from the video lessons.
WKEY and BBAI are continuation patterns that pretty much hit oversold with overall market conditions melting down over the last month due to tariffs.
As the tariff story gets behind us this week I think it’s 110% the best time I’ve ever seen to push as hard as I can as long as I can with small-cap day and swing trades.
I move fast with my trading, trying to get 5-10% quickly on true small-caps in 0-4 days and 10-30% on micro to nano-caps in 0-4 days.
For my big position in long-term LQMT stock, which I buy and sell without notice, I’ve never been this excited about the prospects. The implications of a LiquidMetal hinge are enormous. Like in the billions. Watch this video if you’ve been away.
About seven years ago, I subscribed to a newsletter called BiotechRunup, led by a pharmacist who specialized in trading biotech stocks. The core strategy was to invest six months to a year ahead of key PDUFA dates (deadlines set by the FDA for decisions on drug approvals). Many of these companies had no sales or revenue yet, but their stock prices typically surged significantly as investors anticipated FDA approval.
I believe a similar scenario is unfolding now for LQMT stock, except this time the major event isn't an FDA decision—it's Apple's upcoming foldable iPhone launch. Just like biotech companies anticipating drug approvals, Apple's product launch hype is building momentum for LQMT, reflected in the increasing coverage by news outlets. Specifically, Apple's potential foldable device, featuring a durable LiquidMetal hinge without visible creasing, could revolutionize the market. Since no competitor has successfully solved these technical challenges yet, this innovation could have a transformative impact akin to a groundbreaking drug targeting a major illness. The anticipation alone could significantly boost LQMT's stock price.
And with the CEO’s stock options tied to a share price of $1 or an up listing to the Nasdaq — this might be his path to accomplishing that.
This all started a few week’s ago when one of the most accurate analysts covering Apple products changed his outlook on the hinge from titanium to LQMT.

Coverage so far which I expect to grow. More importantly, now that Ming has leaked this Apple news, I bet LQMT gets contacted by other big companies to start using their tech. And I wouldn’t be shocked if hedge funds start investing too, more on that story later.
Videos
TECH STUDIO (best video)
Matt Talks Tech (better video)
Articles
China Daily (for context only)
Eat. Sleep. & Trade!
Jason Bond
Questions or concerns about our products? Email [email protected]
© Copyright 2022, RagingBull
DISCLAIMER: To more fully understand any Ragingbull.com, LLC ("RagingBull") subscription, website, application or other service ("Services"), please review our full disclaimer located at https://ragingbull.com/disclaimer.
FOR EDUCATIONAL AND INFORMATION PURPOSES ONLY; NOT INVESTMENT ADVICE. Any RagingBull Service offered is for educational and informational purposes only and should NOT be construed as a securities-related offer or solicitation, or be relied upon as personalized investment advice. RagingBull strongly recommends you consult a licensed or registered professional before making any investment decision.
*Sponsored Content: If you purchase anything through a link in this email other than RagingBull services, you should assume that we have an affiliate relationship with the company providing the product or service that you purchase, and that we will be paid in some way. We recommend that you do your own independent research before purchasing anything. We believe in the companies we form affiliate relationships with, but please don’t spend any money on these products or services unless you believe they will help you achieve your goals.
RESULTS PRESENTED NOT TYPICAL OR VERIFIED. RagingBull Services may contain information regarding the historical trading performance of RagingBull owners or employees, and/or testimonials of non-employees depicting profitability that are believed to be true based on the representations of the persons voluntarily providing the testimonial. However, subscribers' trading results have NOT been tracked or verified and past performance is not necessarily indicative of future results, and the results presented in this communication are NOT TYPICAL. Actual results will vary widely given a variety of factors such as experience, skill, risk mitigation practices, market dynamics and the amount of capital deployed. Investing in securities is speculative and carries a high degree of risk; you may lose some, all, or possibly more than your original investment.
RAGINGBULL IS NOT AN INVESTMENT ADVISOR OR REGISTERED BROKER. Neither RagingBull nor any of its owners or employees is registered as a securities broker-dealer, broker, investment advisor(IA), or IA representative with the U.S. Securities and Exchange Commission, any state securities regulatory authority, or any self-regulatory organization.
WE MAY HOLD SECURITIES DISCUSSED. RagingBull has not been paid directly or indirectly by the issuer of any security mentioned in the Services except possibly by advertisers in this email. However, Ragingbull.com, LLC, its owners, and its employees may purchase, sell, or hold long or short positions in securities of the companies mentioned in this communication.
RagingBull.com, LLC shall be entitled to recover attorneys’ fees, costs and disbursements. In the event that any suit or action is instituted as a result of doing business with RagingBull.com, LLC and/or its affiliates or if any suit or action is necessary to enforce or interpret these Terms of Service, RagingBull.com, LLC shall be entitled to recover attorneys’ fees, costs and disbursements in addition to any other relief to which it may be entitled.